Altered intramuscular lipid metabolism relates to diminished insulin action in men, but not women, in progression to diabetes

Obesity

Volumn 18, Issue 11, 2010, Pages 2093-2100

  Perreault, Leigh ^a   Bergman, Bryan C ^a   Hunerdosse, Devon M ^a   Eckel, Robert H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; TRIACYLGLYCEROL;

ARTICLE; BIOPSY; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID METABOLISM; MALE; METABOLISM; MIDDLE AGED; OBESITY; OXIDATION REDUCTION REACTION; SEX DIFFERENCE; SKELETAL MUSCLE;

BIOPSY; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; OXIDATION-REDUCTION; PREDIABETIC STATE; SEX FACTORS; TRIGLYCERIDES;

EID: 78049296939     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.76     Document Type: Article

References (40)

1. Van Genugten RE, Utzschneider KM, Tong J et al.; American Diabetes Association GENNID Study Group. Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects with a family history of type 2 diabetes. Diabetes 2006;55:3529-3535.
2. Williams JW, Zimmet PZ, Shaw JE et al. Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter? Diabet Med 2003;20:915-920.
3. Perreault L, Ma Y, Dagogo-Jack S et al.; Diabetes Prevention Program. Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program. Diabetes Care 2008;31:1416-1421.
4. Nuutila P, Knuuti MJ, Mäki M et al. Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes 1995;44:31-36.
5. Yki-Järvinen H. Sex and insulin sensitivity. Metab Clin Exp 1984;33: 1011-1015.
6. Overweight, obesity, and health risk. National Task Force on the Prevention and Treatment of Obesity. Arch Intern Med 2000;160:898-904.
7. Yamashita S, Nakamura T, Shimomura I et al. Insulin resistance and body fat distribution. Diabetes Care 1996;19:287-291.
8. Steffensen CH, Roepstorff C, Madsen M, Kiens B. Myocellular triacylglycerol breakdown in females but not in males during exercise. Am J Physiol Endocrinol Metab 2002;282:E634-E642.
9. Goodpaster BH, Theriault R, Watkins SC, Kelley DE. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metab Clin Exp 2000;49:467-472.
10. Krssak M, Falk Petersen K, Dresner A et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 1999;42:113-116.
11. Pan DA, Lillioja S, Kriketos AD et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997;46:983-988.
12. Perseghin G, Scifo P, De Cobelli F et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999;48:1600-1606.
13. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002;51:2005-2011.
14. Schmitz-Peiffer C. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 2000;12:583-594.
15. Cooney GJ, Thompson AL, Furler SM, Ye J, Kraegen EW. Muscle long-chain acyl CoA esters and insulin resistance. Ann N Y Acad Sci 2002;967: 196-207.
16. Manco M, Mingrone G, Greco AV et al. Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metab Clin Exp 2000;49:220-224.
17. Roepstorff C, Steffensen CH, Madsen M et al. Gender differences in substrate utilization during submaximal exercise in endurance-trained subjects. Am J Physiol Endocrinol Metab 2002;282:E435-E447.
18. White LJ, Ferguson MA, McCoy SC, Kim H. Intramyocellular lipid changes in men and women during aerobic exercise: a (1)H-magnetic resonance spectroscopy study. J Clin Endocrinol Metab 2003;88:5638-5643.
19. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197.
20. Pritchard JE, Nowson CA, Strauss BJ et al. Evaluation of dual energy X-ray absorptiometry as a method of measurement of body fat. Eur J Clin Nutr 1993;47:216-228.
21. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
22. Bergstrom J. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 1975;35:609-616.
23. WEIR JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol (Lond) 1949;109:1-9.
24. Perreault L, Lavely JM, Bergman BC, Horton TJ. Gender differences in insulin action after a single bout of exercise. J Appl Physiol 2004;97: 1013-1021.
25. Bergman BC, Perreault L, Hunerdosse DM et al. Intramuscular lipid metabolism in the insulin resistance of smoking. Diabetes 2009;58: 2220-2227.
26. Rosendal J, Knudsen J. A fast and versatile method for extraction and quantitation of long-chain acyl-CoA esters from tissue: content of individual long-chain acyl-CoA esters in various tissues from fed rat. Anal Biochem 1992;207:63-67.
27. Patterson BW, Zhao G, Elias N, Hachey DL, Klein S. Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. J Lipid Res 1999;40:2118-2124.
28. Patterson BW, Zhao G, Klein S. Improved accuracy and precision of gas chromatography/mass spectrometry measurements for metabolic tracers. Metab Clin Exp 1998;47:706-712.
29. Wolfe RR. Radioactive and Stable Isotope Tracers in Biomedicine. Wiley-Liss: New York, 1992.
30. Finegood DT, Bergman RN, Vranic M. Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 1987;36:914-924.
31. Blaak EE, Van Aggel-Leijssen DP, Wagenmakers AJ, Saris WH, Van Baak MA. Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 2000;49:2102-2107.
32. Perreault L, Bergman BC, Hunerdosse DM, Playdon MC, Eckel RH. Inflexibility in intramuscular triglyceride fractional synthesis distinguishes prediabetes from obesity in humans. Obesity (Silver Spring) 2009; e-pub ahead of print 24 December 2009.
33. Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 2001;86:5755-5761.
34. Liu L, Zhang Y, Chen N et al. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest 2007;117:1679-1689.
35. Moro C, Bajpeyi S, Smith SR. Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity. Am J Physiol Endocrinol Metab 2008;294:E203-E213.
36. Schenk S, Horowitz J F. Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. J Clin Invest 2007;117:1690-1698.
37. Toledo FG, Menshikova EV, Azuma K et al. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content. Diabetes 2008;57:987-994.
38. Timmers S, Schrauwen P, de Vogel J. Muscular diacylglycerol metabolism and insulin resistance. Physiol Behav 2008;94:242-251.
39. Muoio DM, Dohm GL, Fiedorek FT Jr et al. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 1997;46:1360-1363.
40. Yamauchi T, Kamon J, Minokoshi Y et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8:1288-1295.